Literature DB >> 28012429

Excess mortality among people who report lifetime use of illegal drugs in the United States: A 20-year follow-up of a nationally representative survey.

Elizabeth Reisinger Walker1, Laura A Pratt2, Charlotte A Schoenborn3, Benjamin G Druss4.   

Abstract

OBJECTIVE: The purpose of this study was to determine the mortality risks, over 20 years of follow-up in a nationally representative sample, associated with illegal drug use and to describe risk factors for mortality.
METHODS: We analyzed data from the 1991 National Health Interview Survey, which is a nationally representative household survey in the United States, linked to the National Death Index through 2011. This study included 20,498 adults, aged 18-44 years in 1991, with 1047 subsequent deaths. A composite variable of self-reported lifetime illegal drug use was created (hierarchical categories of heroin, cocaine, hallucinogens/inhalants, and marijuana use).
RESULTS: Mortality risk was significantly elevated among individuals who reported lifetime use of heroin (HR=2.40, 95% CI: 1.65-3.48) and cocaine (HR=1.27, 95% CI: 1.04-1.55), but not for those who used hallucinogens/inhalants or marijuana, when adjusting for demographic characteristics. Baseline health risk factors (smoking, alcohol use, physical activity, and BMI) explained the greatest amount of this mortality risk. After adjusting for all baseline covariates, the association between heroin or cocaine use and mortality approached significance. In models adjusted for demographics, people who reported lifetime use of heroin or cocaine had an elevated mortality risk due to external causes (poisoning, suicide, homicide, and unintentional injury). People who had used heroin, cocaine, or hallucinogens/inhalants had an elevated mortality risk due to infectious diseases.
CONCLUSIONS: Heroin and cocaine are associated with considerable excess mortality, particularly due to external causes and infectious diseases. This association can be explained mainly by health risk behaviors.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cocaine; Drug use; Heroin; Mortality; NHIS

Mesh:

Substances:

Year:  2016        PMID: 28012429      PMCID: PMC5263065          DOI: 10.1016/j.drugalcdep.2016.11.026

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  35 in total

1.  Current estimates from the National Health Interview Survey, 1991.

Authors:  P F Adams; V Benson
Journal:  Vital Health Stat 10       Date:  1992-12

Review 2.  Mortality among cocaine users: a systematic review of cohort studies.

Authors:  Louisa Degenhardt; Jessica Singleton; Bianca Calabria; Jennifer McLaren; Thomas Kerr; Shruti Mehta; Gregory Kirk; Wayne D Hall
Journal:  Drug Alcohol Depend       Date:  2010-09-15       Impact factor: 4.492

3.  Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Wai Tat Chiu; Olga Demler; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

Review 4.  Mortality among amphetamine users: a systematic review of cohort studies.

Authors:  Jessica Singleton; Louisa Degenhardt; Wayne Hall; Tomas Zabransky
Journal:  Drug Alcohol Depend       Date:  2009-07-23       Impact factor: 4.492

5.  Access to medical care, use of preventive services, and chronic conditions among adults in substance abuse treatment.

Authors:  Rhondee Benjamin-Johnson; Alison Moore; Jim Gilmore; Katherine Watkins
Journal:  Psychiatr Serv       Date:  2009-12       Impact factor: 3.084

6.  Mortality associated with illegal drug use among adults in the United States.

Authors:  Pradip K Muhuri; Joseph C Gfroerer
Journal:  Am J Drug Alcohol Abuse       Date:  2011-05       Impact factor: 3.829

Review 7.  Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis.

Authors:  Elizabeth Reisinger Walker; Robin E McGee; Benjamin G Druss
Journal:  JAMA Psychiatry       Date:  2015-04       Impact factor: 21.596

8.  Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Wilson M Compton; Yonette F Thomas; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-05

9.  Exercise-related activities are associated with positive outcome in contingency management treatment for substance use disorders.

Authors:  Jeremiah Weinstock; Danielle Barry; Nancy M Petry
Journal:  Addict Behav       Date:  2008-04-06       Impact factor: 3.913

10.  Double trouble: Psychiatric comorbidity and opioid addiction-all-cause and cause-specific mortality.

Authors:  Karolina M Bogdanowicz; Robert Stewart; Matthew Broadbent; Stephani L Hatch; Matthew Hotopf; John Strang; Richard D Hayes
Journal:  Drug Alcohol Depend       Date:  2015-01-03       Impact factor: 4.492

View more
  16 in total

1.  Worldwide trends in suicide mortality from 1990 to 2015 with a focus on the global recession time frame.

Authors:  Gianfranco Alicandro; Matteo Malvezzi; Silvano Gallus; Carlo La Vecchia; Eva Negri; Paola Bertuccio
Journal:  Int J Public Health       Date:  2019-03-07       Impact factor: 3.380

Review 2.  Mental and Addictive Disorders and Medical Comorbidities.

Authors:  Elizabeth Reisinger Walker; Benjamin G Druss
Journal:  Curr Psychiatry Rep       Date:  2018-08-28       Impact factor: 5.285

3.  Perceived discrimination among racial and ethnic minority drug users and the association with health care utilization.

Authors:  Courtney McKnight; Martha Shumway; Carmen L Masson; Enrique R Pouget; Ashly E Jordan; Don C Des Jarlais; James L Sorensen; David C Perlman
Journal:  J Ethn Subst Abuse       Date:  2017-03-17       Impact factor: 1.507

4.  Estimating vaccination threshold and impact in the 2017-2019 hepatitis A virus outbreak among persons experiencing homelessness or who use drugs in Louisville, Kentucky, United States.

Authors:  Emmanuelle A Dankwa; Christl A Donnelly; Andrew F Brouwer; Rui Zhao; Martha P Montgomery; Mark K Weng; Natasha K Martin
Journal:  Vaccine       Date:  2021-10-20       Impact factor: 4.169

5.  Markers for Severity of Problems in Interpersonal Relationships of Crack Cocaine Users from a Brazilian Multicenter Study.

Authors:  Mayra Pacheco Pachado; Juliana Nichterwitz Scherer; Luciano Santos Pinto Guimarães; Lisia von Diemen; Flavio Pechansky; Felix Henrique Paim Kessler; Rosa Maria Martins de Almeida
Journal:  Psychiatr Q       Date:  2018-12

6.  The contribution of drug-related deaths to the US disadvantage in mortality.

Authors:  Magali Barbieri
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

7.  High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics.

Authors:  Soroush Moallef; Fahmida Homayra; M-J Milloy; Lorna Bird; Bohdan Nosyk; Kanna Hayashi
Journal:  Subst Abus       Date:  2020-12-03       Impact factor: 3.716

8.  Associations between illicit drug use in early adulthood and mortality: Findings from a National Birth Cohort.

Authors:  James White
Journal:  Prev Med       Date:  2022-04-22       Impact factor: 4.637

9.  Physical Activity and the Development of Substance Use Disorders: Current Knowledge and Future Directions.

Authors:  Angelique G Brellenthin; Duck-Chul Lee
Journal:  Prog Prev Med (N Y)       Date:  2018-05

10.  Which Psychopathological Syndromes Could Be Associated with the Risk of Suicide among Substance Users?

Authors:  Laura Masferrer; Elisenda Escalé-Muntañà; Rafel Malagón; Jordi Cid; Beatriz Caparrós
Journal:  Int J Environ Res Public Health       Date:  2018-10-17       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.